Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Medical Journal of BabylonOpen Access

Assessment of Apo Lipoprotein A-I and High-Density Lipoprotein Levels in Patients with Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

HDHussein Bahaa DeaibilAAArshad Noori Al-DujailiHSHayder Jaber Sagban

Discussion

Loading...

Member takes

Overview

Analysis reveals decreased ApoA-I and HDL levels in men with prostate cancer, suggesting their role in cancer progression.

Key Points

  • Prostate cancer patients showed significantly lower ApoA-I and HDL levels compared to benign conditions and controls.
  • ApoA-I and HDL levels were markedly reduced in newly diagnosed and tumor-treated patients at grade IV versus lower grades.
  • This study assessed ApoA-I and HDL levels in 180 male patients, divided into four distinct groups based on prostate conditions.
  • Findings indicate the potential of using low levels of ApoA-I and HDL as markers for early prostate cancer detection.

Cite This Study

Deaibil et al. (2025) studied this question.

synapsesocial.com/papers/68dd91dafe798ba2fc499525https://doi.org/10.4103/mjbl.mjbl_272_23
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lipid Profile, PCSK9 , ANGPTL3 and Lipoprotein (a) Levels in Men Diagnosed With Localized High‐Grade Prostate Cancer and Men At‐Risk of Prostate Cancer2025 · 2 citations
  2. 2Serum and urine apolipoprotien A1 (ApoA1) as biomarkers in bladder cancer2024
  3. 3ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer2026 · 1 citations
  4. 4Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer2017 · 91 citations
  5. 5Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study2024 · 1 citations